Kamiński R, Przywara B, Gasior M, Kleinrok Z, Czuczwar S J
Department of Pharmacology and Toxicology, Medical University School, Lublin, Poland.
J Neural Transm (Vienna). 1998;105(2-3):133-46. doi: 10.1007/s007020050043.
5-Fluoroindole-2-carboxylic acid, an antagonist of the glycine site within the NMDA receptor complex, administered intraperitoneally in doses of 150 and 200 mg/kg, 120 min before electroconvulsions, significantly raised the convulsive threshold from 6.8 to 7.9 and 8.3 mA, respectively. At lower doses, it did not influence the threshold. However, lethality was observed 24h after administration of the threshold-elevating doses of this glycine site antagonist. 5-Fluoroindole-2-carboxylic acid (100 mg/kg), applied together with carbamazepine, valproate or phenobarbital, significantly reduced their ED50 values against maximal electroshock - from 13.9 to 7.5 mg/kg, from 291 to 242 mg/kg, and from 18.6 to 11.1 mg/kg, respectively. At the dose of 50 mg/kg, it also potentiated the protective activity of carbamazepine. However, 5-fluoroindole-2-carboxylic acid, up to 100 mg/kg, did not affect the anti-convulsive activity of diphenylhydantoin. When applied at doses equal to their ED50 values against maximal electroshock-induced convulsions, carbamazepine (13.9 mg/kg), phenobarbital (18.6 mg/kg) and valproate (291 mg/kg) did not affect the motor performance of mice in the chimney test. 5-Fluoroindole-2-carboxylic acid (100 mg/kg produced a significant motor impairment, at 50 mg/kg it did not affect the motor performance. The combined treatment of 5-fluoroindole-2-carboxylic acid (100 mg/kg) with carbamazepine, phenobarbital or valproate, providing a 50% protection against maximal electroshock, resulted in motor impairment. Only the combination of 5-fluoroindole-2-carboxylic acid (50 mg/kg) with carbamazepine (8.6 mg/kg) did not significantly influence this parameter. Almost all of the antiepileptic drugs studied, when administered at doses equal to their ED50 values against maximal electroshock, did not influence retention in the passive avoidance task, which is a measure of long-term memory. Only valproate (291 mg/kg) worsened long-term memory. The combined treatment of 5-fluoroindole-2-carboxylic acid (100 mg/kg) with carbamazepine or phenobarbital, providing a 50% protection against maximal electroshock, did not affect the retention. The combination of 5-fluoroindole-2-carboxylic acid (100 mg/kg) with valproate (242 mg/kg) caused a significant impairment of long-term memory and mortality of 50% of animals 24h following the administration. The results suggest that the blockade of the strychnine-insensitive glycine site may lead to an enhancement of the protective activity of some conventional antiepileptic drugs, which is associated with pronounced side-effects and lethality in some cases.
5-氟吲哚-2-羧酸是N-甲基-D-天冬氨酸(NMDA)受体复合物中甘氨酸位点的拮抗剂,在惊厥前120分钟腹腔注射150和200mg/kg剂量,可使惊厥阈值分别从6.8显著提高到7.9和8.3mA。较低剂量时,它不影响阈值。然而,在给予该甘氨酸位点拮抗剂提高阈值的剂量后24小时观察到致死性。5-氟吲哚-2-羧酸(100mg/kg)与卡马西平、丙戊酸盐或苯巴比妥联合应用,可显著降低它们对最大电休克的半数有效剂量(ED50)值,分别从13.9降至7.5mg/kg、从291降至242mg/kg以及从18.6降至11.1mg/kg。在50mg/kg剂量时,它还增强了卡马西平的保护活性。然而,高达100mg/kg的5-氟吲哚-2-羧酸不影响苯妥英的抗惊厥活性。当以它们对最大电休克诱导惊厥的ED50值剂量给药时,卡马西平(13.9mg/kg)、苯巴比妥(18.6mg/kg)和丙戊酸盐(291mg/kg)不影响小鼠在烟囱试验中的运动表现。5-氟吲哚-2-羧酸(100mg/kg)产生显著的运动障碍,50mg/kg时不影响运动表现。5-氟吲哚-2-羧酸(100mg/kg)与卡马西平、苯巴比妥或丙戊酸盐联合治疗,对最大电休克提供50%的保护,导致运动障碍。只有5-氟吲哚-2-羧酸(50mg/kg)与卡马西平(8.6mg/kg)的组合对该参数没有显著影响。几乎所有研究的抗癫痫药物,当以它们对最大电休克的ED50值剂量给药时,不影响被动回避任务中的记忆保持,被动回避任务是长期记忆的一种测量方法。只有丙戊酸盐(291mg/kg)使长期记忆恶化。5-氟吲哚-2-羧酸(100mg/kg)与卡马西平或苯巴比妥联合治疗,对最大电休克提供50%的保护,不影响记忆保持。5-氟吲哚-2-羧酸(100mg/kg)与丙戊酸盐(242mg/kg)的组合导致长期记忆显著受损,给药后24小时动物死亡率为50%。结果表明,对士的宁不敏感的甘氨酸位点的阻断可能导致一些传统抗癫痫药物的保护活性增强,在某些情况下这与明显的副作用和致死性有关。